Antibacterial Lidocaine Wound Gel
NDC Package 51142-652-28
Package Information
Antibacterial Lidocaine Wound Gel (benzalkonium chloride, lidocaine hydrochloride) gel is clean the affected areaadults and children 2 years of age and older: apply to affected area not more than 3 to 4 times dailychildren under 2 years of age: consult a doctormay be covered with a sterile bandageif bandaged, let dry first. This formulation utilizes a gel delivery system. Marketed by Aso Llc, this product is identified by NDC 51142-652 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1431682 - benzalkonium chloride 0.13 % / lidocaine HCl 2 % Topical Gel
- RxCUI: 1431682 - benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel
- RxCUI: 1431682 - benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51142 - Aso Llc
- 51142-652 - Antibacterial Lidocaine Wound Gel
- 51142-652-28 - 1 TUBE in 1 CARTON / 28 mL in 1 TUBE
- 51142-652 - Antibacterial Lidocaine Wound Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51142-652). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51142-652-28 identifies a specific commercial package of 1 tube in 1 carton / 28 ml in 1 tube of Antibacterial Lidocaine Wound Gel, a human over the counter drug labeled by Aso Llc. This gel is formulated for topical use and contains benzalkonium chloride; lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aso Llc on October 28, 2019. The current certification is valid through December 31, 2026.
How is this Aso Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51142065228. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.